Related references
Note: Only part of the references are listed.Critique of the Two-Fold Measure of Prediction Success for Ratios: Application for the Assessment of Drug-Drug Interactions
Eleanor J. Guest et al.
DRUG METABOLISM AND DISPOSITION (2011)
Sources of interindividual variability in IVIVE of clearance: an investigation into the prediction of benzodiazepine clearance using a mechanistic population-based pharmacokinetic model
Helen E. Cubitt et al.
XENOBIOTICA (2011)
Effect of Obesity on the Pharmacokinetics of Drugs in Humans
Michael J. Hanley et al.
CLINICAL PHARMACOKINETICS (2010)
A Semi-Mechanistic Model to Predict the Effects of Liver Cirrhosis on Drug Clearance
Trevor N. Johnson et al.
CLINICAL PHARMACOKINETICS (2010)
Systems Clinical Pharmacology
A. J. Atkinson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Prediction of Human Intestinal First-Pass Metabolism of 25 CYP3A Substrates from In Vitro Clearance and Permeability Data
Michael Gertz et al.
DRUG METABOLISM AND DISPOSITION (2010)
Population-Based Mechanistic Prediction of Oral Drug Absorption
Masoud Jamei et al.
AAPS JOURNAL (2009)
Estimation of creatinine clearance in morbidly obese patients
Jasmina A. Demirovic et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2009)
Comparison of Drug Dosing Recommendations Based on Measured GFR and Kidney Function Estimating Equations
Lesley A. Stevens et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Pharmacotherapy for obesity
Mingfang Li et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
A Framework for Assessing Inter-individual Variability in Pharmacokinetics Using Virtual Human Populations and Integrating General Knowledge of Physical Chemistry, Biology, Anatomy, Physiology and Genetics: A Tale of 'Bottom-Up' vs 'Top-Down' Recognition of Covariates
Masoud Jamei et al.
DRUG METABOLISM AND PHARMACOKINETICS (2009)
Assessment of inter-individual variability in predicted phenytoin clearance
Thomas M. Polasek et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
The Simcyp® Population-based ADME Simulator
Masoud Jamei et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
Covariation of Human Microsomal Protein Per Gram of Liver with Age: Absence of Influence of Operator and Sample Storage May Justify Interlaboratory Data Pooling
Z. E. Barter et al.
DRUG METABOLISM AND DISPOSITION (2008)
Whole body physiologically-based pharmacokinetic models: their use in clinical drug development
Andrea N. Edginton et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
Prediction of intestinal first-pass drug metabolism
Jiansong Yang et al.
CURRENT DRUG METABOLISM (2007)
Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data:: Reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver
Zoe E. Barter et al.
CURRENT DRUG METABOLISM (2007)
Obesity-induced increase of CYP2E1 activity and its effect on disposition kinetics of chlorzoxazone in Zucker rats
Phisit Khemawoot et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Change in liver size and fat content after treatment with Optifast® very low calorie diet
Mark C. Lewis et al.
OBESITY SURGERY (2006)
Body surface area in normal-weight, overweight, and obese adults. A comparison study
J Verbraecken et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
Hemodynamic monitoring in obese patients: The impact of body mass index on cardiac output and stroke volume
HT Stelfox et al.
CRITICAL CARE MEDICINE (2006)
So many studies, too few subjects: Establishing functional relevance of genetic polymorphisms on pharmacokinetics
JA Williams et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children
Trevor N. Johnson et al.
CLINICAL PHARMACOKINETICS (2006)
Prediction of in vivo drug clearance from in vitro data. I: Impact of inter-individual variability
E. M. Howgate et al.
XENOBIOTICA (2006)
Changes in liver volume from birth to adulthood: A meta-analysis
TN Johnson et al.
LIVER TRANSPLANTATION (2005)
Estimation of renal function in subjects with normal serum creatinine levels: Influence of age and body mass index
JC Verhave et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
What is the best size descriptor to use for pharmacokinetic studies in the obese?
B Green et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Central fat mass versus peripheral fat and lean mass: Opposite (adverse versus favorable) associations with arterial stiffness? The Amsterdam Growth and Health Longitudinal Study
I Ferreira et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
A standard weight descriptor for dose adjustment in the obese patient
SB Duffull et al.
CLINICAL PHARMACOKINETICS (2004)
The effects of weight loss on renal function in patients with severe obesity
A Chagnac et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
The 3D scanner for measuring body surface area: a simplified calculation in the Chinese adult
CY Yu et al.
APPLIED ERGONOMICS (2003)
A central body fat distribution is related to renal function impairment, even in lean subjects
SJ Pinto-Sietsma et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans
ZQ Wang et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Liver volume and visceral obesity in women with hepatic steatosis undergoing gastric banding
L Busetto et al.
OBESITY RESEARCH (2002)
Body surface area and body weight predict total liver volume in Western adults
JN Vauthey et al.
LIVER TRANSPLANTATION (2002)
Predicting the impact of physiological and biochemical processes on oral drug bioavailability
B Agoram et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Relations of stroke volume and cardiac output to body composition - The strong heart study
T Collis et al.
CIRCULATION (2001)
Contrasting clinical properties and exercise responses in obese and lean hypertensive patients
MA Weber et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Effects of obesity on pharmacokinetics - Implications for drug therapy
G Cheymol
CLINICAL PHARMACOKINETICS (2000)
Glomerular filtration rate in severely overweight normotensive humans
P Anastasio et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)
Glomerular hyperfiltration in hypertensive African Americans
TA Kotchen et al.
HYPERTENSION (2000)
Share Paper
